A Reconfigurable Microfluidic Platform for Sample-Efficient Antibody Fc Biomarker Discovery
Precise diagnosis of infectious diseases is often hindered by a lack of accessible biomarkers that can distinguish between active and past infections. While antibody levels are commonly measured, they typically fail to provide this distinction, especially in endemic contexts where antibodies can persist long...